Dukes criteria, 236–237
DVD.SeeDegenerative valvular disease (DVD)
Dysentery, severe gastrointestinal fluid
losses and, 330
Eagle effect, 314
EA method.SeeEndotracheal aspirates (EA) method
Ebola virus, 332, 476
EBV.SeeEpstein-Barr virus (EBV)
Echinocandins, 545
Ecthyma gangrenosum, 221, 310, 364
Efalizumab, 379
EHEC.SeeEnterohemorrhagicE. coli(EHEC)
Ehrlichia chaffeensis, 390
EIA, for CDI diagnosis, 280
Eikenella corrodens, 221
EKG.SeeElectrocardiogram (EKG)
Electrocardiogram (EKG), 113
Electrolyte adverse reactions, 549–540
ELISA.SeeEnzyme-linked immunosorbent
assays (ELISA)
EM.SeeErythema migrans (EM)
EMB.SeeEthambutol (EMB)
Emphysematous cholecystitis
clinical and radiologic diagnosis of, 84
mimic of, 84
Empiric antibiotic therapy
for CAP, 172, 173–175
CVC infections, 209
of urosepsis, 292–293
for VAP, 190–191
Empiric antimicrobial therapy, 488–491, 536
antibiotic susceptibility data, 491
antimicrobial exposure, 488
clinical syndrome, 488–491
cost, 491
duration of hospitalization, 488
epidemiology, 491
of MDRA. baumannii, 517–519
severe illness, 491
Empiric therapy
of meningitis, 148–150
pneumonia, 346
of sepsis, 130, 131
Encephalitis
clinical and radiologic diagnosis of, 90–91
clinical approach, 154–155
patient with altered brain function, 162
diagnostic approach, 161–162
infectious
bacterial brain infections, 155–159
etiologic agents and diagnostic approach, 156
vein brain infections, 159–161
mimics of, 92, 153–162
Encephalopathy, 153
Endemic mycoses, 328, 381
Endocarditis, 135, 346
Endoscopic variceal sclerotherapy, 345
Endoscopy
CDI diagnosis and, 278
Endotracheal aspirates (EA) method, 188
Gram stain technique and, 188–189
Endotracheal suction systems, 185
Endotracheal-tube-associated pneumonia, 178
Entamoeba histolytica, 330
Enterobacteriaceae, 389, 392, 398
ESBL production and, 222
Enterobacterspp., 397
Enterococcus, 352
Enterococcus casseliflavus, 112
Enterococcus faecalis, 112, 342, 397
Enterococcus faecium, 112, 494
Enterococcus gallinarium, 112
Enterococcusspp.
IE and, 218
skin and soft tissue infections and, 296
EnterohemorrhagicE. coli(EHEC), 330
Enterotoxin, 308-kDa, 275
Enteroviruses, 135
Enzyme-linked immunosorbent assays (ELISA),
157, 426
Eosinophilia
fever and, 49, 331
Eosinophilic meningoencephalitis, 329
Epidemiology
miliary tuberculosis, 420
Epididymal, physical findings
diagnostic features, 61
noninfectious mimics, 61
PE findings, 61
Epstein-Barr virus (EBV), 399
Epstein-Barr virus-positive Hodgkin’s
lymphoma, 476
Ertapenem, 191
Erysipelas, 297–298
treatment of, 298
Erysipelothrix rhusiopathiae, 300
Erythema, physical findings
diagnostic features, 52
noninfectious mimics, 52
PE findings, 52
Erythema migrans (EM), 29, 157
arm of patient with Lyme disease, 30
Erythema multiforme, 30–31
causes of, 31
Erythema nodosum, 40
causes of, 40
Erythrocyte sedimentation rate (ESR), 10
Erythromycin, 548
ESBL.SeeExtended spectrumb-lactamases (ESBL)
Eschar
intranasal, physical findings
diagnostic features, 53
noninfectious mimics, 53
PE findings, 53
Escherichia coli, 76, 79, 82, 84, 135, 342, 352, 397, 488
Esculin hydrolysis, 498
ESR.SeeErythrocyte sedimentation rate
E-test, 189–190
defined, 189
Ethambutol (EMB), 427564 Index